Medical Doctor Program year 2023 Source: CMS Open Payments, 2026 publication

Thurman Wheeler

Neuromuscular Medicine Rochester, NY Medical Doctor

NPI 1255773149 CMS profile 1196458

601 Elmwood Ave., Box 645, Rochester, NY 14642

Open in the dashboard

General payments

$95

1 record reported · program year 2023

Research payments

$0

Paid to them · None reported · program year 2023

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$270,422 paid to institutions, not to them · program years 2020–2023

Through program year 2023, Thurman Wheeler of Rochester, NY is reported in the CMS Open Payments database as having received $95 across 1 general payment and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $270,422 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 8th percentile of Neuromuscular Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

1 row
Year Kind Relative to this record's peak year Amount Records
2023 General $95 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Thurman Wheeler
  • Neuromuscular Medicine median
  • Middle half of Neuromuscular Medicine
  • National median

In program year 2025, general payments to Thurman Wheeler were reported at $0. Among 188 Neuromuscular Medicine profiles paid that year, the median was $530 and the middle half received between $134 and $6,440.

Show as a table
Year Thurman Wheeler Neuromuscular Medicine median Middle half National median
2019 $0 $356 $114–$4,219 $163
2020 $0 $287 $72–$5,632 $114
2021 $0 $193 $73–$1,841 $132
2022 $0 $362 $109–$2,461 $149
2023 $95 $411 $119–$3,356 $160
2024 $0 $394 $122–$5,116 $164
2025 $0 $530 $134–$6,440 $169

Breakdown

Who paid General payments · program year 2023
  1. Sarepta Therapeutics, Inc. $95 1 payment

Every payment, record by record

What the payments were for General payments · program year 2023
  1. Food and Beverage $95 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

20

Median for Neurology: 833

Drug cost

$158

Median for Neurology: $202,670

Branded share of claims

0%

Median for Neurology: 25.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Prednisone Generic 20 $158

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,695 Part D prescribers listed as Neurology; they describe a distribution and say nothing about conduct.

Records

1 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neuromuscular Medicine in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record